2021 Cause

We believe in science.

In the wake of the great scientific achievement that is the COVID-19 vaccine, it feels like a good time to turn our attention to the fight against rare diseases. For far too long, so many diseases have received minimal funding. Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig’s Disease, is just one of many such diseases.

According to Johns Hopkins, ALS affects approximately 30,000 individuals in the United States, with 5,000 new cases diagnosed each year. ALS causes motor neurons to die in the brain and spinal cord. An afflicted person progressively loses the ability to walk, speak, swallow, and breathe. Many will die within two to five years of diagnosis, and the disease affects people of all ages.

To that end, we have chosen Project ALS as our charity of the year.

“Project ALS identifies and funds the most promising scientific and medical research that will lead to the first effective treatments and a cure for ALS. We recruit the world’s best scientists and doctors to work together—rationally and aggressively—to develop a better understanding of the ALS disease process and, in parallel, better therapeutic strategies.”

Project ALS Mission Statement